This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Learn ways to combine income boosting with debt payoff strategies. Enhance your financial wellness effectively.
28,655 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
When markets glow with optimism, Buffett’s rulebook still applies. This guide explains how to read sentiment, guard a...
Johnson & Johnson and AbbVie report strong Q1 2026 results, showcasing two contrasting growth paths as biosimilar cha...
When a daughter tried sell mother’s assets, a routine real estate conversation uncovered a troubling pattern of elder...
Ripple merges Swell with XRPL Apex for its biggest New York conference yet, stitching together enterprise payments an...
OpenAI accelerates its shift from software to silicon and bio bets, unveiling a custom chip, a DRAM stake, and a majo...
Colorado regulators announced a settlement with Unlock Technologies to reclassify home equity agreements as consumer ...
Fresh analyst calls on Tuesday cover a diverse set of names from Blackstone to Qualcomm, signaling continued caution ...
Nio stunned investors with its first quarterly net profit, driving a sharp rally on a market day shaped by mixed indi...
The Trade Desk slid again amid reports of agency cautions and analyst downgrades. This piece explains the drivers, wh...
A new Goldman Sachs study argues physical infrastructure and skilled labor will cap AI expansion even as demand for a...
SpaceX is pursuing a bold, trillion-dollar plan to become the backbone of global connectivity. As markets watch, inve...